NHS faces £2.7 billion annual cost from bed-blocking as healthcare systems grapple with treatment efficacy, safety concerns, and environmental health improvements.

NHS bed-blocking costs have reached £2.7 billion annually according to King's Fund analysis, with one in 10 hospital beds occupied by patients medically fit for discharge, highlighting critical system inefficiencies in patient flow and resource management.

Dupilumab demonstrates superior treatment continuation rates for atopic eczema compared to traditional therapies like oral or subcutaneous methotrexate and ciclosporin, offering improved real-world patient adherence benefits.

Social needs screening in US pediatric practices increases discussion and referral rates but fails to translate into higher actual service enrollment, raising questions about the effectiveness of screening-without-support interventions.

Cortisol levels normalize within 4 weeks after discontinuing combined oral contraceptives, with serum corticosteroid-binding globulin and total cortisol decreasing rapidly, according to new Dutch research on hormonal contraceptive effects.

Right heart reserve measured by TAPSE/PASP ratio predicts outcomes in heart failure patients undergoing interatrial shunting, with lower ratios linked to increased cardiovascular death and hospitalization rates.

Blood lead and mercury levels have dropped significantly among UK pregnant women since the early 1990s, representing major environmental and public health improvements in maternal and fetal exposure to toxic heavy metals.

Dapagliflozin reduces major adverse cardiovascular events in type 2 diabetes patients at high risk for advanced liver fibrosis, expanding the cardiovascular benefits of SGLT2 inhibitors to hepatic-compromise populations.

Maternal RSV vaccination late in pregnancy is safe regarding birth outcomes but shows a slightly elevated risk for hypertensive disorders of pregnancy, requiring careful risk-benefit assessment in clinical practice.